Salomon Manier, MD, PhD, of Lille University, a hematologist who is involved in the MajesTEC-7 trial, discusses what nurses should know about the challenges and practical considerations that accompany the use of bispecific antibodies as a treatment for multiple myeloma. “In the field of multiple myeloma, we’ve had the recent progress, and we are still in the learning curve with those bispecific antibodies,” Dr. Manier told Cancer Nursing Today at the European Hematology Association 2024 Congress. “The data are very encouraging in terms of safety and efficacy, but we are facing new challenges and new ...
Multiple Myeloma
Learn about the newest therapies, interventions, and clinical research on multiple myeloma (MM). Cancer Nursing Today provides the latest clinical data and insights on screening for early detection, COVID-19 vaccine responses in patients with MM, and more. From treatment developments for relapsed/refractory MM and imaging techniques to the latest in CAR T-cell therapy, explore the latest outcomes in MM.
Advertisement
Currently, there is no standardization of melphalan administration.
A real-world study presented at the EHA 2024 Congress provided insights on patient and caregiver experiences.
The risk of hospitalization was associated with the number of drugs in a patient's myeloma treatment regimen.
With 3 FDA-approved BiTEs for myeloma, oncology nurses must be able to understand BiTEs and explain them to patients.
Talquetamab is a T-cell redirecting bispecific antibody targeting GPRC5D on myeloma cells.
Due to the unique challenges associated with administering these therapies, a team aimed to standardize the workflow.
Misinformation or fake news can mislead patients with multiple myeloma.
Nurse researchers noted patients had “feelings of confusion at the time of initial diagnosis" of multiple myeloma.
The study showed that nursing support was a “key environmental facilitator" for physical activity in these patients.
Although CRAB describes end-organ symptoms of multiple myeloma, it does not provide a full picture.
Advertisement
Trending
Studying for certification tests can be intimidating. Here are some essential tips to help you do your best.
These tips are important resources for oncology nurses who are recent graduates and experienced nurses new to this specialty.
With the shift in cancer care to the ambulatory care setting, a dedicated oncology nurse educator is a key asset to nurses.
Gastroparesis occurs in 60% of patients with advanced pancreatic cancer, and is frequently overlooked in upper GI tumors.
More unique, non-traditional jobs are emerging for oncology nurses to consider outside traditional positions.
Alkaline phosphatase may serve as a discriminating marker in detecting bone lesions in patients with multiple myeloma.
Advertisement
Expert Contributor
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®, is the owner of beyond Oncology Education, LLC.
Advertisement
Latest News
Learn how a team developed and implemented an escape room game to help studnets learn about oncologic emergencies.
In the United States, 33%-50% of patients receiving an allogeneic transplant develop acute GVHD.
A new study highlights why it's critical for oncology nurses to identify patients who are at risk of frailty.
